Close Menu

NEW YORK – Qiagen said on Friday afternoon that it has received several "conditional, non-binding indications of interest" from potential merger or acquisition partners.

As such, the company has begun a review of potential strategic alternatives, it said.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.